Tuesday, July 17, 2012


Truvada (Tenofovir/emtricitabine), is a fixed-dose combination of two antiretroviral drugs, consisting of 300 milligrams of tenofovir and 200 milligrams of emtricitabine. The drug has been just approved for use as a pre-exposure prophylaxis against HIV infection. It significantly decreased the risk of contracting HIV. It is approved for non-infected men who have sex with multiple male partners.

Side effects include nausea, vomiting, dizziness and renal toxicity. Also, Lactic acidosis, steatosis and post treatment exacerbation of Hepatitis B.

No comments:

Post a Comment